High-Risk Skin Cancers With Atezolizumab Plus NT-I7

Clinical trial NCT03901573 · TERMINATED

Trial details

NCT number: NCT03901573
Sponsor: NeoImmuneTech
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Melanoma Merkel Cell Carcinoma Cutaneous Squamous Cell Carcinoma

Start date: 2019-12-26
Primary completion: 2023-08-15
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.